IL77533A - Thrombolytic product containing an antibody and pharmaceutical compositions containing the same - Google Patents

Thrombolytic product containing an antibody and pharmaceutical compositions containing the same

Info

Publication number
IL77533A
IL77533A IL77533A IL7753386A IL77533A IL 77533 A IL77533 A IL 77533A IL 77533 A IL77533 A IL 77533A IL 7753386 A IL7753386 A IL 7753386A IL 77533 A IL77533 A IL 77533A
Authority
IL
Israel
Prior art keywords
antibody
same
pharmaceutical compositions
compositions containing
thrombolytic
Prior art date
Application number
IL77533A
Other languages
English (en)
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/689,851 external-priority patent/US5116613A/en
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of IL77533A publication Critical patent/IL77533A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL77533A 1985-01-08 1986-01-06 Thrombolytic product containing an antibody and pharmaceutical compositions containing the same IL77533A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/689,851 US5116613A (en) 1985-01-08 1985-01-08 Antibody-thrombolytic agent product and method of use
US77446985A 1985-09-10 1985-09-10

Publications (1)

Publication Number Publication Date
IL77533A true IL77533A (en) 1990-11-05

Family

ID=27104496

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77533A IL77533A (en) 1985-01-08 1986-01-06 Thrombolytic product containing an antibody and pharmaceutical compositions containing the same

Country Status (6)

Country Link
EP (1) EP0187658B1 (de)
JP (1) JP2573927B2 (de)
AT (1) ATE129901T1 (de)
AU (1) AU595173B2 (de)
DE (1) DE3650432T2 (de)
IL (1) IL77533A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
EP0241907A3 (de) * 1986-04-14 1989-09-13 The General Hospital Corporation Heterobifunktionelle Antikörper und Verfahren zur Verwendung derselben
US5716990A (en) * 1987-03-09 1998-02-10 Cancer Research Campaign Technology Limited Drug delivery systems
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
US5811265A (en) * 1988-08-19 1998-09-22 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5609869A (en) * 1988-08-19 1997-03-11 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5162218A (en) * 1988-11-18 1992-11-10 The Regents Of The University Of California Conjugated polypeptides and methods for their preparation
KR900701847A (ko) * 1988-11-18 1990-12-04 원본미기재 복합 폴리펩티드, 그들의 제조 방법 및 사용 방법
CA2051436A1 (en) * 1989-04-03 1990-10-04 Christoph Bode Platelet specific immunoconjugates
DK176290D0 (da) * 1990-07-24 1990-07-24 Novo Nordisk As Terapeutisk og diagnostisk praeparat
EP0673391A4 (de) * 1991-10-01 1995-11-22 Gen Hospital Corp Auf der oberfläche von aktivierten blutplättchen exprimiertes aktivierungsabhängiges protein und dagegen gerichtete antikörper.
US5961973A (en) 1992-03-06 1999-10-05 Crea; Roberto Pathogen-targeted biocatalysts
US5302707A (en) * 1992-03-26 1994-04-12 Affymax Technologies N.V. 5-fluorouridine nucleoside phosphate compounds
US5446132A (en) * 1992-10-01 1995-08-29 The General Hospital Corporation Thrombin-activated platelet protein-2 (TAPP-2)
US20030017147A1 (en) * 1996-09-20 2003-01-23 Guy L Reed Composition and method for enhancing fibrinolysis
GB0108332D0 (en) * 2001-04-03 2001-05-23 Univ Durham Lectin directed prodrug delivery system
CN100482546C (zh) 2002-06-20 2009-04-29 株式会社吉野工业所 袋状吹塑成型容器
US11220680B2 (en) * 2018-11-21 2022-01-11 Immunwork Inc. Polypeptide for treating pathological blood clots

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
EP0142905A2 (de) * 1983-03-30 1985-05-29 Bio-Response Inc. Therapeutisches Mittel für die Behandlung von Krankheiten wie Krebs
EP0146050B1 (de) * 1983-12-16 1990-07-04 Denis M. Callewaert Stellenselektiver Plasminogenaktivator und Verfahren zu seiner Herstellung und Verwendung

Also Published As

Publication number Publication date
JP2573927B2 (ja) 1997-01-22
DE3650432T2 (de) 1996-04-18
EP0187658A3 (en) 1988-09-07
AU5162285A (en) 1986-07-17
EP0187658A2 (de) 1986-07-16
AU595173B2 (en) 1990-03-29
EP0187658B1 (de) 1995-11-08
DE3650432D1 (de) 1995-12-14
ATE129901T1 (de) 1995-11-15
JPS61239889A (ja) 1986-10-25

Similar Documents

Publication Publication Date Title
IL77533A (en) Thrombolytic product containing an antibody and pharmaceutical compositions containing the same
McClintock et al. The mechanism of activation of human plasminogen by streptokinase
GR3007381T3 (de)
AU3256489A (en) Reaction vessel for performing sequential analytical assays
AU585035B2 (en) Process and device for catalytic cracking of charges of hydrocarbons, with temperature control of the reaction
FR2586187B1 (fr) Systeme pour fournir des matieres (agents) a un milieu environnant, instantanement et en continu
FI832633A7 (fi) Vermikuliitti immobilisoitujen biologisten materiaalien kantaja- alustana.
CS193069B2 (en) Method of tracking the enzymatic and other biochemical reactions
AU5285779A (en) Preparation of solid pharmaceuticals
AU590653B2 (en) Catalyst for vapor-phase intermolecular dehydration reaction of alkanolamines
CA1031676A (en) Method and reagent for the enzyme kinetic determination of the concentration of a substrate
NO880974D0 (no) Innretning til termostatisering og blanding av innholdet av en mikrotitreringsplates kar.
DE3669266D1 (de) Mischmethode fuer reaktions-ausgangsmaterial und apparat dafuer.
AU5626080A (en) Catalytic reaction process
BR8803143A (pt) Composicao de organopolissiloxano
GB8817493D0 (en) Method & apparatus for assembly of friction components
NO832720L (no) Fremgangsmaate for isomerisering av styrenoksyd til fenylaldehyd.
AU7050087A (en) Signal enhancement in immunoassay by modulation of chemical catalysis
AU591200B2 (en) Process for preparing finely divided metal powders
BR7507475A (pt) Veiculo para medicao imuno-quimica,processo de sua preparacao,sistema de reacao para a medicao imuno-quimica e processo para medicao imuno-quimica de componentes biologicos
AU559263B2 (en) Process and apparatus for gas phase catalytic reactions
ES2032941T3 (es) Procedimiento de carbonilacion.
AR244770A1 (es) Metodo para agregar acido borico o un borato a una zona de mezcla o reaccion.
AU1062588A (en) Immunoassay utilizing microparticle neutralization
DK0460143T3 (da) Middel til transdermal applikation indeholdende rolipram

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
RH1 Patent not in force